Patents by Inventor Katherine J. MARTIN

Katherine J. MARTIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180223369
    Abstract: Clinical tests for testing therapeutic sensitivity of cancerous breast tissue and methods and kits for performing the same are described herein. Embodiments of the present invention are directed to methods for predicting the efficacy of treatment of breast cancer. In addition, certain embodiments are directed to a kit for testing therapeutic sensitivity of breast cancer tissue.
    Type: Application
    Filed: August 18, 2017
    Publication date: August 9, 2018
    Inventors: Marcia V. FOURNIER, Katherine J. MARTIN
  • Patent number: 9771618
    Abstract: Clinical tests for testing therapeutic sensitivity of cancerous breast tissue and methods and kits for performing the same are described herein. Embodiments of the present invention are directed to methods for predicting the efficacy of treatment of breast cancer. In addition, certain embodiments are directed to a kit for testing therapeutic sensitivity of breast cancer tissue.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: September 26, 2017
    Assignee: Bioarray Genetics, Inc.
    Inventors: Marcia V. Fournier, Katherine J. Martin
  • Publication number: 20140162887
    Abstract: Methods and compositions for determining and/or predicting a response to a therapy, prognosis of a cancer subject or survival of a cancer and kits for performing the same are described herein.
    Type: Application
    Filed: February 6, 2012
    Publication date: June 12, 2014
    Applicant: BIOARRAY THERAPEUTICS, INC.
    Inventors: Katherine J. Martin, Marcia V. Fournier
  • Publication number: 20130236567
    Abstract: Disclosed are methods and compositions for determining and/or predicting a response to a therapy, especially a cancer therapy, including chemotherapy. Specifically, the disclosure provides profiles of a set of marker genes in breast cancers from patients who were known to have responded or not responded to a chemotherapy for predicting response to the same therapy including different combination of chemotherapy in a patient diagnosed with breast cancer. The disclosure further provides computer complemented methods for the prediction based on genetic profiles as well as different clinical parameters. Furthermore, the disclosure provides kits for performing the method disclosed.
    Type: Application
    Filed: June 6, 2011
    Publication date: September 12, 2013
    Inventors: Katherine J. Martin, David Magee, Marcia V. Fournier
  • Publication number: 20110045480
    Abstract: Clinical tests for testing therapeutic sensitivity of cancerous breast tissue and methods and kits for performing the same are described herein. Embodiments of the present invention are directed to methods for predicting the efficacy of treatment of breast cancer. In addition, certain embodiments are directed to a kit for testing therapeutic sensitivity of breast cancer tissue.
    Type: Application
    Filed: August 19, 2010
    Publication date: February 24, 2011
    Inventors: Marcia V. FOURNIER, Katherine J. MARTIN